Market Analysis and Insights: Global and United States Bioburden Testing Market
This report focuses on global and United States Bioburden Testing market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Bioburden Testing market size is estimated to be worth US$ 598 million in 2022 and is forecast to a readjusted size of US$ 898.9 million by 2028 with a CAGR of 7.0% during the review period. Fully considering the economic change by this health crisis, by Type, Instruments accounting for % of the Bioburden Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Pharmaceutical was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Bioburden testing is a process of measuring viable microorganisms on medical devices, raw material, or package. The process helps in determining parameters for its sterilization process to ensure safety and effectiveness of medical devices.
Global Bioburden Testing Scope and Market Size
Bioburden Testing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Bioburden Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Bioburden Testing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Instruments
Consumables
Segment by Application
Pharmaceutical
Biotechnology
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Charles River Laboratories International
Sigma-Aldrich
SGS
Wuxi Pharmatech (CAYMAN)
Merck
Becton Dickinson
North American Science Associates Inc.
Nelson Laboratories
Pacific Biolabs
ATS Labs